Human umbilical cord mesenchymal stem cells alleviate the imbalance of CD4<sup>+</sup> T cells <i>via</i> protein tyrosine phosphatase non-receptor type 2/signal transducer and activator of transcription 3 signaling in ameliorating experimental autoimmune thyroiditis in rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Human umbilical cord mesenchymal stem cells alleviate the imbalance of CD4<sup>+</sup> T cells <i>via</i> protein tyrosine phosphatase non-receptor type 2/signal transducer and activator of transcription 3 signaling in ameliorating experimental autoimmune thyroiditis in rats

Published:2022 Issue:6 Volume:69 Page:613-625
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Gao Junjie¹,Hu Jianxia²,Li Peng³,Che Kui²,Wang Fei³,Yan Shengli³

Affiliation:

1. Medical College, Qingdao University, Qingdao, China

2. The Laboratory of Thyroid Disease, Affiliated Hospital of Qingdao University, Qingdao, China

3. Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao, China

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/69/6/69_EJ20-0695/_pdf

Reference49 articles.

1. 1 Ramos-Levi AM, Marazuela M (2016) Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr 63: 421–429.

2. 2 Mincer DL, Jialal I (2021) Hashimoto Thyroiditis. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, Florida, USA.

3. 3 Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Rolinski J (2015) Immune disorders in Hashimoto’s thyroiditis: what do we know so far? J Immunol Res 2015: 979167.

4. 4 Rydzewska M, Jaromin M, Pasierowska IE, Stozek K, Bossowski A (2018) Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res 11: 2.

5. 5 Yasuda K, Takeuchi Y, Hirota K (2019) The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol 41: 283–297.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future;Frontiers in Pharmacology;2023-08-21

2. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment;Cell Transplantation;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3